Serum low density lipoprotein subclasses in asthma
Authors:
- Nicola ScichiloneNicola Scichilone
- Manfredi RizzoManfredi Rizzo
- Alida BenfanteABAlida Benfante
- Roberta CataniaRCRoberta Catania
- Rosaria Vincenza GiglioRGRosaria Vincenza Giglio
- Dragana NikolicDNDragana Nikolic
- Giuseppe MontaltoGMGiuseppe Montalto
- Vincenzo BelliaVBVincenzo Bellia
- 1 December 2013
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 107 (12) , 1866-1872
Abstract
No abstract availableKeywords
Funding Information
- University of Palermo
This publication has 42 references indexed in Scilit:
- Emerging roles for cholesterol and lipoproteins in lung diseasePulmonary Pharmacology & Therapeutics, 2013
- Statins, systemic inflammation and risk of death in COPD: The Rotterdam studyPulmonary Pharmacology & Therapeutics, 2013
- Lovastatin-induced decrease of intracellular cholesterol level attenuates fibroblast-to-myofibroblast transition in bronchial fibroblasts derived from asthmatic patientsEuropean Journal of Pharmacology, 2013
- Statins as potential therapeutic drug for asthma?Respiratory Research, 2012
- A Systematic Review of Statin Efficacy in AsthmaJournal of Asthma, 2012
- New Kids on the BlockChest, 2011
- Apolipoprotein E Negatively Regulates House Dust Mite–induced Asthma via a Low-Density Lipoprotein Receptor–mediated PathwayAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Hypercholesterolemia Impairs Immunity to TuberculosisInfection and Immunity, 2008
- SR-BI inhibits ABCG1-stimulated net cholesterol efflux from cells to plasma HDLJournal of Lipid Research, 2008
- Potential therapeutic role for statins in respiratory diseaseThorax, 2006